Hydromethylthionine could slow cognitive decline: Minimum dose
Sunday, December 1, 2019 - 14:00
in Health & Medicine
Researchers have reported unexpected results of a pharmacokinetic analysis of the relationship between treatment dose, blood levels and pharmacological activity of the drug hydromethylthionine on the brain in over 1,000 patients with mild-to-moderate Alzheimer's disease.